Expression of Fibroblast Activation Protein Is Enriched in Neuroendocrine Prostate Cancer and Predicts Worse Survival.
Panagiotis J VlachostergiosAthanasios KarathanasisVasileios TzortzisPublished in: Genes (2022)
expression may serve as a valuable NE marker indicating a worse prognosis in patients with metastatic CRPC.